Back to Search
LAWRENCE BLONDE, MD
MD
Endocrinology, Diabetes & Metabolism Physician
NPI: 1821055237Individual
Specialties, Licenses & Credentials
Endocrinology, Diabetes & Metabolism PhysicianPrimary
Internal Medicine — Endocrinology, Diabetes & Metabolism
Code: 207RE0101X
MD.03383R(LA)
Research & Publications (20)
Comparison of vildagliptin and thiazolidinedione as add-on therapy in patients inadequately controlled with metformin: results of the GALIANT trial--a primary care, type 2 diabetes study.
PMID 19614942·Diabetes Obes Metab·2009
4-observational
Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study.
PMID 19515182·Diabetes Obes Metab·2009
4-observational
Predicted risk of diabetes and coronary heart disease in patients with schizophrenia: aripiprazole versus standard of care.
PMID 18435564·J Clin Psychiatry·2008
2-rct
Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes.
PMID 16776751·Diabetes Obes Metab·2006
2-rct
Sildenafil citrate for erectile dysfunction in men with diabetes and cardiovascular risk factors: a retrospective analysis of pooled data from placebo-controlled trials.
PMID 17076971·Curr Med Res Opin·2006
1-meta
Reducing cardiovascular disease risk in patients with diabetes: a message from the National Diabetes Education Program.
PMID 17064330·J Am Acad Nurse Pract·2006
6-review
What are incretins, and how will they influence the management of type 2 diabetes?
PMID 16981805·J Manag Care Pharm·2006
8-other
Current evidence regarding the value of self-monitored blood glucose testing.
PMID 16224939·Am J Med·2005
6-review
Best practices in diabetes management: getting more patients to goal.
PMID 16111441·Am J Manag Care·2005
8-other
Durable efficacy of metformin/glibenclamide combination tablets (Glucovance) during 52 weeks of open-label treatment in type 2 diabetic patients with hyperglycaemia despite previous sulphonylurea monotherapy.
PMID 15529514·Int J Clin Pract·2004
3-trial
Gastrointestinal tolerability of extended-release metformin tablets compared to immediate-release metformin tablets: results of a retrospective cohort study.
PMID 15119994·Curr Med Res Opin·2004
4-observational
Greater reductions in A1C in type 2 diabetic patients new to therapy with glyburide/metformin tablets as compared to glyburide co-administered with metformin.
PMID 14617228·Diabetes Obes Metab·2003
4-observational
Glyburide/metformin combination product is safe and efficacious in patients with type 2 diabetes failing sulphonylurea therapy.
PMID 12406033·Diabetes Obes Metab·2002
3-trial
Management of type 2 diabetes: update on new pharmacological options.
PMID 11729412·Manag Care·2000
4-observational
Long-term outcomes in patients with type 2 diabetes receiving glimepiride combined with liraglutide or rosiglitazone.
PMID 19245711·Cardiovasc Diabetol·2009
3-trial
Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6).
PMID 19515413·Lancet·2009
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1514 JEFFERSON HWY
NEW ORLEANS, LA 70121 - Phone
- (504) 842-4000
Quick Facts
- NPI
- 1821055237
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile